Celecoxib 100 Mg Capsules Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 100 mg, 200 mg

Reference Brands: Celebrex (USA), Celecoxib Sandoz

Category: Analgesic

Celecoxib 100mg Capsules is used mostly to relieve the condition of inflammation of joints due to degeneration of cartilage tissue it’s called osteoarthritis and a long-term stage of inflammation of the joints it’s called rheumatoid arthritis. This capsule works by stopping the body's production of natural substances that cause pain and inflammation. Celecoxib 100 mg Capsules is available in Capsules and strengths such as 100 mg, 200 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Celecoxib 100 mg Capsules is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Celecoxib 100 mg Capsules can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

The following side-effects may commonly occur when using Celecoxib Capsules. • accidental injury • cough • influenza-like illness • insomnia • joint pain • nausea • diarrhea • dizziness • gas formation • headache • heart attack • high blood pressure • increased muscle tone

Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) that possesses anti-inflammatory, analgesic, and antipyretic properties. It is commonly prescribed for the management of conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute pain. By reducing inflammation, swelling, and joint stiffness, celecoxib helps improve mobility and overall quality of life in patients suffering from chronic musculoskeletal and inflammatory disorders.

Celecoxib works by selectively inhibiting the cyclooxygenase-2 (COX-2) enzyme, which plays a key role in the synthesis of prostaglandins responsible for pain and inflammation in the body. Unlike many traditional NSAIDs that inhibit both COX-1 and COX-2 enzymes, celecoxib specifically targets COX-2. This selective inhibition helps provide effective anti-inflammatory and pain-relieving effects while reducing the risk of serious gastrointestinal side effects commonly associated with non-selective NSAIDs.

In addition to its use in pain and inflammatory conditions, celecoxib has also been studied for its potential role in reducing the formation of adenomatous colorectal polyps in patients with familial adenomatous polyposis (FAP), a hereditary condition associated with an increased risk of colorectal cancer. Due to its targeted mechanism of action and therapeutic effectiveness, celecoxib remains an important option in the treatment of inflammatory and pain-related conditions.